HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

TCR-like human antibodies expressed on human CTLs mediate antibody affinity-dependent cytolytic activity.

Abstract
The permanent genetic programming via gene transfer of autologous T cells with cell surface receptors directed toward tumor-related Ags holds great promise for the development of more-specific tumor therapies. In this study we have explored the use of Abs directed to MHC-peptide complexes (or TCR-like Abs) to engraft CTLs with exquisite specificity for cancer cells. First, we affinity matured in vitro a previously selected TCR-like Ab, Fab-G8, which is highly specific for the peptide melanoma-associated Ag-A1 presented by the HLA-A1 molecule. A combination of L chain shuffling, H chain-targeted mutagenesis, and in vitro selection of phage display libraries yielded a Fab-G8 Ab derivative, Fab-Hyb3, with an 18-fold improved affinity yet identical peptide fine specificity. Fab-G8 and Fab-Hyb3 were expressed on primary human T lymphocytes as cell surface-anchored Fab, demonstrating that T cells expressing the high-affinity Fab-Hyb3 molecule eradicate tumor cells much more effectively. Furthermore, the gain in ligand-binding affinity resulted in a 2-log improvement in the detection of peptide/MHC complexes on melanoma-associated Ag-A1 peptide-loaded cells. In summary, an affinity-matured Ab specifically recognizing a cancer-related peptide/MHC complex was generated and used to improve the tumor cell killing capacity of human T cells. This strategy, based on engraftment of T cells with in vitro engineered Abs, is an attractive alternative to the laborious, and in many cases unsuccessful, generation of highly potent tumor-specific T lymphocytes.
AuthorsPatrick Chames, Ralph A Willemsen, Gertrudis Rojas, Detlef Dieckmann, Louise Rem, Gerold Schuler, Reinder L Bolhuis, Hennie R Hoogenboom
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 169 Issue 2 Pg. 1110-8 (Jul 15 2002) ISSN: 0022-1767 [Print] United States
PMID12097420 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, Neoplasm
  • HLA-A1 Antigen
  • Immunodominant Epitopes
  • Immunoglobulin Fab Fragments
  • Immunoglobulin Heavy Chains
  • Immunoglobulin Light Chains
  • Melanoma-Specific Antigens
  • Neoplasm Proteins
  • Receptors, Antigen, T-Cell
  • Receptors, Antigen, T-Cell, gamma-delta
Topics
  • Antibody Affinity (genetics)
  • Antibody Specificity
  • Antigen Presentation (genetics)
  • Antigens, Neoplasm
  • Cloning, Molecular
  • Cytotoxicity, Immunologic (genetics)
  • Gene Targeting
  • Genetic Vectors (chemical synthesis)
  • HLA-A1 Antigen (immunology)
  • Humans
  • Immunodominant Epitopes (immunology, metabolism)
  • Immunoglobulin Fab Fragments (biosynthesis, genetics, metabolism, physiology)
  • Immunoglobulin Heavy Chains (biosynthesis, chemistry, metabolism)
  • Immunoglobulin Light Chains (biosynthesis, chemistry, metabolism)
  • Melanoma-Specific Antigens
  • Neoplasm Proteins (immunology)
  • Protein Binding (genetics, immunology)
  • Receptors, Antigen, T-Cell (biosynthesis, genetics, metabolism, physiology)
  • Receptors, Antigen, T-Cell, gamma-delta (biosynthesis, genetics, metabolism)
  • T-Lymphocytes, Cytotoxic (immunology, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: